http://www.fpnotebook.com/
PneumoniaAka: Bacterial Pneumonia, Atypical Pneumonia, Community-Acquired Pneumonia, CAP
- See Also
- Definition: Community Acquired Pneumonia (CAP)
- Lower respiratory tract infection
- Develops in non-hospitalized patient
- May be bacterial, viral, fungal or parasitic
- May be present despite normal Chest XRay
- Epidemiology: Community acquired pneumonia
- Adults: 346 Israeli patients admitted for pneumonia
- Pneumococcal Pneumonia (43%)
- Mycoplasma pneumonia (29%)
- Chlamydia pneumoniae (18%)
- Legionella pneumonia (16%)
- References
- Adults: 346 Israeli patients admitted for pneumonia
- Causes: Community Acquired Pneumonia
- See Pneumonia Causes
- Bacteria: Typical
- Bacteria: Atypical
- Virus
- Adenovirus
- Influenza A and B
- Parainfluenza
- Respiratory Syncytial Virus
- Fungus
- Risk Factors
- Age over 65 years
- Recent antibiotics
- Immune compromised (e.g. HIV Infection)
- Respiratory illness (COPD, Asthma)
- Vascular disease (CHF, CVA)
- Diabetes Mellitus
- Chronic Liver Disease
- Chronic Kidney Disease
- Cancer
- Signs and Symptoms
- Bacterial Pneumonia
- Cough
- Productive of Purulent Sputum with typical bacteria
- Non-productive in atypical cases
- Sudden onset
- Fever and Chills
- Fatigue
- Ill appearing patient
- Pleuritic Chest Pain
- Dyspnea
- Tachypnea
- Tachycardia
- Cough
- Viral Pneumonia
- Non-productive cough
- Gradual Onset with prodrome (malaise and Headache)
- Chest XRay more impressive than exam
- Onset in fall or winter
- Wheezing more common in viral causes
- Low grade temperature (<101.3 F)
- Mycoplasma pneumonia
- Constant, harsh, non-productive cough
- Wheezing may occur in Mycoplasma pneumonia
- Fever typically lasts longer than 3 days
- More common in age over 3 years
- Legionella
- Bacterial Pneumonia
- Exam (* denotes high correlation with bacterial CAP)
- Diagnosis
- Labs
- General
- Lab Indications
- Moderate or severe community acquired pneumonia
- Patient with comorbid conditions
- Efficacy of Labs
- No value in non-severe community acquired pneumonia
- Theerthakarai (2001) Chest 119:181
- Lab Indications
- Sputum Examination
- Tests
- Efficacy of Sputum exam
- Sputum has low diagnostic yield in CAP
- Not recommended in community acquired pneumonia
- Ewig (2002) Chest 121:1486
- Blood Culture
- Indications
- Not indicated unless severe disease
- Recommended by ATS in hospitalized CAP
- Efficacy
- Low sensitivity: Positive in only 5-10% of cases
- Does not predict severity or outcome
- References
- Indications
- Specific Testing with reasonable efficacy
- Chlamydia pneumonia
- Rapid PCR (>30% Test Sensitivity)
- Influenza
- Legionella pneumophila
- Rapid PCR of Sputum (80% Test Sensitivity)
- Urinary antigen (>50% Test Sensitivity)
- Mycoplasma pneumoniae
- Rapid PCR of Sputum (>30% Test Sensitivity)
- Chlamydia pneumonia
- General
- Radiology: Chest XRay
- Indications: All cases of suspected CAP
- Precautions: False negatives in early presentation
- Serial Chest XRays may be needed
- Does not exclude pneumonia in severe illness
- Positive in only 40% of acute pneumococcal CAP
- Interpretation
- Lobar infiltrate suggests typical bacterial CAP
- Diffuse, bilateral infiltrates suggests atypical CAP
- Differential Diagnosis
- See Pneumonia Causes
- See Cough Causes
- Acute Respiratory Distress Syndrome
- Severe Acute Respiratory Syndrome
- Churg-Strauss Syndrome
- Congestive Heart Failure
- Inflammatory Lung Disease
- Idiopathic Pulmonary Fibrosis
- Interstitial pneumonitis
- Pulmonary Embolism
- Lung Cancer
- Sarcoidosis
- Wegener's Granulomatosis
- Bronchiolitis Obliterans with Organizing Pneumonia
- Bioterrorism Agents
- Management
- See Pneumonia Management
- Convert to oral antibiotic within 72 hours if possible
- See Pneumonia Hospitalization Criteria
- See Pneumonia Hospitalization Criteria in the Elderly
- Prognosis: Predictors of increased mortality
- See Pneumonia Prognostic Factors in Older Patients
- Comorbid neurologic disease
- Renal disease
- Congestive Heart Failure
- Hypotension
- Tachypnea
- Hypothermia
- Prevention
- Resources
- References
Pneumonia, Bacterial (C0004626) | |
|---|---|
| Definition (MSH) | Pneumonia caused by various species of bacteria. Bacterial pneumonia commonly results from bronchogenic spread of infection following microaspiration of secretions. The largest category of this disease arises from community-acquired pneumonias. |
| Definition (CSP) | pneumonia caused by various species of bacteria; commonly results from bronchogenic spread of infection following microaspiration of secretions. |
| Concepts | Disease or Syndrome (T047) |
| ICD9 | 482.9 |
| English | BACT PNEUMONIA, Bacterial pneumonia, Bacterial Pneumonias, PNEUMONIA BACT |
| Spanish | neumonÃa bactérica, neumonÃa bacteriana, neumonia bacteriana, neumonia bacterica |
| Credits | Derived from the NIH UMLS (Unified Medical Language System) |
capsule (pharmacologic) (C0006935) | |
|---|---|
| Definition (MSH) | Hard or soft soluble containers used for the oral administration of medicine. |
| Definition (NCI) | A solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI) |
| Definition (NCI) | A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed. |
| Definition (NCI) | A solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. |
| Definition (HL7V3.0) | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin. |
| Concepts | Biomedical or Dental Material (T122) |
| English | CAP, Caps, Capsule, Capsule Dosage Form, Capsule Dose Form, Capsules, Drug capsule |
| Spanish | cápsula, cápsula medicamentosa, capsula, capsula medicamentosa, fármaco en cápsula, farmaco en capsula, medicamento en cápsula, medicamento en capsula |
| Credits | Derived from the NIH UMLS (Unified Medical Language System) |
Pneumonia (C0032285) | |
|---|---|
| Definition (MSH) | Inflammation of the lungs. |
| Definition (CSP) | inflammation of the lungs with consolidation and exudation. |
| Definition (NCI) | (noo-MONE-ya) An inflammatory infection that occurs in the lung. |
| Definition (NCI) | An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness. |
| Concepts | Disease or Syndrome (T047) |
| Basque | NEUMONIA |
| Danish | Lungebetaendelse |
| Dutch | Pneumonie |
| English | Lung Inflammation, Lung Inflammations, Pneumonia, Pneumonias, Pneumonitides, Pneumonitis, Pulmonary Inflammation, Pulmonary Inflammations |
| Finnish | KEUHKOKUUME |
| French | Pneumonie |
| German | Pneumonie |
| Hebrew | daleket reot |
| Hungarian | pneumonia |
| Italian | Polmonite |
| Norwegian | LUNGEBETENNELSE |
| Portuguese | Pneumonia |
| Spanish | neumonÃa, Neumonia, neumonitis |
| Swedish | LUNGINFLAMMATION/PNEUMONI |
| Credits | Derived from the NIH UMLS (Unified Medical Language System) |
Atypical pneumonia (C1412002) | |
|---|---|
| Concepts | Disease or Syndrome (T047) |
| English | atypical pneumonia |
| Spanish | neumonÃa atÃpica, neumonia atipica |
| Credits | Derived from the NIH UMLS (Unified Medical Language System) |
